Skip to main content
LLY
NYSE Life Sciences

Eli Lilly to Ink $2 Billion AI Drug Development Deal, Acquire GLP-1 Rights

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$875
Mkt Cap
$829.778B
52W Low
$623.78
52W High
$1,133.95
52W Position info
40% above low
Off High info
23% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

LLY sits 40% above its 52-week low of $623.78.

Summary

Eli Lilly is reportedly set to sign a $2 billion deal with Hong Kong biotech Insilico Medicine, focusing on AI-driven drug development. The agreement also includes Eli Lilly acquiring exclusive rights to sell a GLP-1 drug for diabetes from Insilico Medicine. This strategic move follows a period of exceptional financial performance for Eli Lilly, largely fueled by its successful GLP-1 agonists like Mounjaro and Zepbound, and recent positive clinical trial results for other pipeline assets. The deal is significant as it not only invests in cutting-edge artificial intelligence for drug discovery but also further strengthens Eli Lilly's already dominant position in the highly lucrative GLP-1 market for diabetes and obesity. Traders will be watching for further details on the specific GLP-1 asset and the expected impact of this AI partnership on Lilly's long-term pipeline and development timelines.

At the time of this announcement, LLY was trading at $875.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $829.8B. The 52-week trading range was $623.78 to $1,133.95. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 09, 2026, 10:23 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1,394.15
Real-time Price: $1,411.12 info
Change: +$16.97 (+1%) info
Market Cap: $1.328T info
LLY
Nov 06, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,346.00
Real-time Price: $1,411.12 info
Change: +$65.12 (+5%) info
Market Cap: $1.328T info
LLY
Nov 04, 2026, 1:53 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,416.54
Real-time Price: $1,411.12 info
Change: -$5.42 (-0.38%) info
Market Cap: $1.328T info
LLY
Oct 29, 2026, 3:21 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1,368.10
Real-time Price: $1,411.12 info
Change: +$43.02 (+3%) info
Market Cap: $1.328T info
LLY
Oct 29, 2026, 12:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1,370.30
Real-time Price: $1,411.12 info
Change: +$40.82 (+3%) info
Market Cap: $1.328T info